Score Overview
Explore the 2021 public Archive ranking →
Where Thermo Fisher Scientific Inc has ranked, year by year
Showing 20 years ranking history by HDB Score.
Top 50 on HDB Score for 1 year, since 2021, through 2021.
- TMO
2006: 19.5% · 2021: 1.9% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-14 | $ 613.62 | — |
1 Year2025-09-12 | $ 477.72 | 28.45% |
5 Years2021-09-14 | $ 554.85 | 10.59% |
10 Years2016-09-14 | $ 143.83 | 326.62% |
20 Years2006-09-14 | $ 37.40 | 16x |
30 Years1996-09-13 | $ 31.61 | 19x |
| Period | Last Price2026-09-14 | 1 Year2025-09-12 | 5 Years2021-09-14 | 10 Years2016-09-14 | 20 Years2006-09-14 | 30 Years1996-09-13 |
|---|---|---|---|---|---|---|
| Price | $ 613.62 | $ 477.72 | $ 554.85 | $ 143.83 | $ 37.40 | $ 31.61 |
| Return | — | 28.45% | 10.59% | 326.62% | 16x | 19x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 46.33B | $ 6.97B | $ 4.06B |
| 2025 | $ 44.55B | $ 6.73B | $ 10.10B |
| 2024 | $ 42.87B | $ 6.33B | $ 5.58B |
| 2023 | $ 42.85B | $ 5.99B | $ 8.08B |
| 2022 | $ 44.91B | $ 6.95B | $ 8.52B |
| 2021 | $ 39.21B | $ 7.72B | $ 4.47B |
| 2020 | $ 32.21B | $ 6.37B | $ 10.32B |
| 2019 | $ 25.54B | $ 3.69B | $ 2.39B |
| 2018 | $ 24.35B | $ 2.93B | $ 2.10B |
| 2017 | $ 20.91B | $ 2.22B | $ 1.33B |
| 2016 | $ 18.27B | $ 2.02B | $ 786M |
| 2015 | $ 16.96B | $ 1.97B | $ 452M |
| 2014 | $ 16.88B | $ 1.89B | $ 1.34B |
| 2013 | $ 13.09B | $ 1.27B | $ 5.83B |
| 2012 | $ 12.50B | $ 1.17B | $ 809M |
| 2011 | $ 11.72B | $ 1.32B | $ 1.02B |
| 2010 | $ 10.78B | $ 1.03B | $ 926M |
| 2009 | $ 10.10B | $ 850M | $ 1.57B |
| 2008 | $ 10.49B | $ 994M | $ 1.28B |
| 2007 | $ 9.74B | $ 761M | $ 639M |
| 2006 | $ 3.79B | $ 168M | $ 691M |
| 2005 | $ 2.63B | $ 223M | $ 294M |
| 2004 | $ 2.20B | $ 361M | $ 512M |
| 2003 | $ 2.09B | $ 200M | $ 418M |
| 2002 | $ 2.08B | $ 309M | $ 875M |
| 2001 | $ 2.18B | $ 1.04B | |
| 2000 | $ 2.28B | -$ 36M | $ 1.02B |
| 1999 | $ 2.47B | -$ 174M | $ 838M |
| 1998 | $ 3.86B | $ 181M | $ 1.54B |
| 1997 | $ 3.55B | $ 239M | $ 1.52B |
| 1996 | $ 2.93B | $ 190M | $ 1.84B |
| 1995 | $ 2.20B | $ 140M | $ 1.05B |
| 1994 | $ 1.58B | $ 103M | $ 382M |
| 1993 | $ 1.24B | $ 76M | $ 325M |
| 1992 | $ 949M | $ 59M | $ 190M |
| 1991 | $ 805M | $ 47M | $ 131M |
| 1990 | $ 708M | $ 33M | $ 117M |
| 1989 | $ 579M | $ 24M | $ 93M |
| 1988 | $ 500M | $ 20M | $ 136M |
| 1987 | $ 383M | $ 18M | $ 144M |
| 1986 | $ 331M | $ 14M | $ 63M |
| 1985 | $ 265M | $ 9M | $ 30M |
Thermo Fisher Scientific Inc fundamental performance
Between 2005 and 2025, revenue grew from $ 2.63B to $ 44.55B and net income grew from $ 223M to $ 6.73B. Revenue increased in 18 of those 20 years; net income in 16.
Across Thermo Fisher Scientific Inc's full reported history, from 1985 to 2025, revenue grew from $ 265M to $ 44.55B and net income grew from $ 9M to $ 6.73B. Revenue increased in 85% of the years measured; net income in 77%.
Thermo Fisher Scientific Inc currently holds a 20-year HDB Score of 9.0 out of 10. How the HDB Score is calculated.
Membership
Continue TMO’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,827 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
